Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:09 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2185–2208 of 2,531 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Baseline Control Clear all

Conditions: Cardiovascular Diseases, Inflammation
Interventions: Canola Oil, Palm Oil, Butter; Other
Lead sponsor: Ohio State University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Pulmonary Arterial Hypertension
Interventions: MTT with antibiotic preconditioning + fiber supplementation, MTT with antibiotic preconditioning + placebo supplementation, MTT with placebo + placebo supplementation.; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: COVID-19
Interventions: Double-Blind NT-I7, Double-Blind Placebo; Drug
Lead sponsor: NeoImmuneTech; Industry
Eligibility: 19 Years to 75 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: Bethesda, Maryland • Omaha, Nebraska

Conditions: Cardiovascular Diseases
Interventions: Healthy Heart Score; Behavioral
Lead sponsor: Ohio University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Dublin, Ohio

Conditions: Pediatric Obesity, Nutrition Disorder
Interventions: Nourish to Flourish: The Power of Positive Food Parenting; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 5 Years and older
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Atopic Dermatitis
Interventions: Narrow band UVB treatment (NB-UVB); Other
Lead sponsor: Rockefeller University; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Lung Cancer, Breast Cancer, Prostate Cancer, Multiple Myeloma, Melanoma
Interventions: mHealth Intervention; Behavioral
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: PreDiabetes, Older Adult, Muscle Loss, Muscle Weakness
Interventions: Vivo; Behavioral
Lead sponsor: Impactiv, Inc.; Industry
Eligibility: 60 Years and older
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Stress, Habits
Interventions: Personalized Anchoring Strategy, Non-Anchoring Strategy Control, Fixed Anchoring Strategy; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 174 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Rhinitis, Allergic, Perennial
Interventions: Placebo, TAA-AQ, Nasacort® AQ, Claritin®; Other · Drug
Lead sponsor: Sanofi; Industry
Eligibility: 3 Years to 9 Years
Enrollment: 299 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Allergic Asthma
Interventions: Placebo, Omalizumab, Immunotherapy; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 275 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: PreDiabetes, Type 2 Diabetes, Healthy
Interventions: Time Restrictive Eating- late, Time Restrictive Eating- early, Time Restrictive Eating- early with early caloric intake, Macronutrient-controlled meals; Behavioral · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Stanford, California

Conditions: Depression, Anxiety, Emotion Regulation
Interventions: Common Elements Toolbox (COMET); Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 829 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Chronic Low Back Pain (CLBP), Aging
Interventions: Trunk control training; Other
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 60 Years to 85 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Asthma
Interventions: Sirukumab, Placebo, Rescue medication; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 5
States / cities: Long Beach, California • Aventura, Florida • Cincinnati, Ohio + 1 more

Conditions: Depressive Disorder, Major
Interventions: Seltorexant, Placebo; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 74 Years
Enrollment: 588 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 51
States / cities: Anaheim, California • Cerritos, California • Irvine, California + 42 more

Conditions: Anemia
Interventions: Inhaled Nitric Oxide, Placebo; Drug
Lead sponsor: New York Medical College; Other
Eligibility: 2 Weeks and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 4
States / cities: Springfield, Massachusetts • Stony Brook, New York • Valhalla, New York + 1 more

Conditions: Low Back Pain
Interventions: Spinal manipulation treatment; Procedure
Lead sponsor: Michigan State University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 3
States / cities: East Lansing, Michigan • Lansing, Michigan

Conditions: Sickle Cell Disease, Attention Deficit, Cognitive Deficit in Attention
Interventions: EndeavorRx; Device
Lead sponsor: Children's National Research Institute; Other
Eligibility: 8 Years to 16 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Dry Age-related Macular Degeneration
Interventions: Valeda Light Delivery System, Valeda Light Delivery System Sham Mode; Device
Lead sponsor: LumiThera, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 10
States / cities: Beverly Hills, California • Palo Alto, California • Altamonte Springs, Florida + 7 more

Conditions: Cochlear Implant, Cochlear Implant Users, Cochlear Implant Recipients, Cochlear Implant Listeners
Interventions: AC Group, CA group; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 95 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Breast Pain, Mastalgia, Back Pain, Back Pain, Low, Neck Pain, Chest Pain, Activity, Motor, Healthy Aging, Weight, Body, Inflammation, Gonadal Steroid Hormones, Neuronal Plasticity, Neuromuscular Manifestations
Interventions: Interventional Sports bra; Other
Lead sponsor: University of Houston; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Intolerance of Uncertainty; Anxiety
Interventions: Active IU CBM-I, Control CBM-I; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Obesity &Amp; Overweight, Sedentary Behaviors, Cardiometabolic Risk, Physical Inactivity
Interventions: E-Bike Commuting; Behavioral
Lead sponsor: University of Wisconsin, River Falls; Other
Eligibility: 18 Years to 30 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: River Falls, Wisconsin

Search by objective public record fields.

The Effects of Consuming Palm Oil With Different Macronutrient Intakes on Blood Lipids

Microbiota Transplant With Antibiotic Preconditioning and Fiber Supplementation in PAH.

A Trial of NT-I7 in COVID-19 (SPESELPIS)

Healthy Heart Score Intervention In the Primary Care Setting

A Positive Food Parenting Intervention to Promote Healthy Growth in Children at Risk for Obesity

Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis

Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS)

Examining the Effects of Vivo on Physical Function and Glycemic Level in Sedentary Older With Prediabetes.

Mindfulness Takes Practice

Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)

Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma

Effect of Meal Composition and Timing Modification on Glucose Metabolism, Body Temperature and Sleep

Efficacy of COMET on Prolific Participants

Trunk Control Training and Walking in Older Adults

A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma

A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO

Trunk Motor Control Performance Before and After Spinal Manipulation Treatment

Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)

Patient-Oriented Research to Optimize Cochlear Implant Outcomes

Hormones, Outcomes, and Pain Pathways in Exercise Study

Computerized Cognitive Bias Intervention for Intolerance of Uncertainty

E-Bike Commuting and Health in Overweight College Students